Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
about
Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer.CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
P2860
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cell line and patient-derived ...... h-grade serous ovarian cancer.
@en
type
label
Cell line and patient-derived ...... h-grade serous ovarian cancer.
@en
prefLabel
Cell line and patient-derived ...... h-grade serous ovarian cancer.
@en
P2093
P2860
P50
P356
P1476
Cell line and patient-derived ...... gh-grade serous ovarian cancer
@en
P2093
Alexander J Crandon
Anna V Tinker
Anna deFazio
Brittney S Harrington
C Blake Gilks
Catherine Kennedy
Catherine M Shannon
Claire M Davies
Deborah K Roche
Donal J Brennan
P2860
P2888
P304
P356
10.1038/BJC.2015.471
P407
P577
2016-02-04T00:00:00Z